DIBUCAINE CHOLINESTERASE - ANVISA Registration 80146501806
Access comprehensive regulatory information for DIBUCAINE CHOLINESTERASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146501806 and manufactured by SENTINEL CH.SPA. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including SENTINEL CH. SPA, ROCHE DIAGNOSTICS GMBH, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80146501806
25351286260201257
56998701000116
Company Information
Dates and Status
Jul 23, 2012
VIGENTE
09/18/2025 19:00:01
DIBUCAรNA COLINESTERASE
DIBU (Dibucain)_cobas c
ROCHE DIAGNOSTICS GMBH
10287411475
Feb 10, 2020
DIBUCAรNA COLINESTERASE
Alinity c Dibucaine CHE Reagent Kit
SENTINEL CH. SPA
80146502233
Nov 18, 2019

